MediPharm Labs Reports Fourth Quarter and Full Year 2020 Results
BARRIE, Ontario, March 31, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or...
Staff
Natural Colors transaction closed
Divestment of Natural Colors to EQT closed as of March 31, 2021 Chr. Hansen Holding A/S and EQT today announced...
BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem® Program
Notice of Allowance Grants Protection for Deriving Exosomes from Brown AdipocytesMELVILLE, N.Y., March 31, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies,...
Microbix Announces Annual and Special Meeting Voting Results
MISSISSAUGA, Ontario, March 31, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF)( “Microbix®” or the Company”), a...
OncoResponse Raises $40.6 Million Series C Financing
- New capital will fund lead antibody, OR2805, through Phase 1 and 2 clinical studies - Adds Magnetar Group, Yonjin Ventures...
Better Choice Company Reports Fourth Quarter and Full Year 2020 Financial Results
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (OTCQX: BTTR) (the “Company” or “Better Choice”), an...
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage...
Cara Therapeutics to Host Virtual Research and Development Event on April 7, 2021
STAMFORD, Conn., March 31, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and...
CareDx Enhances Leadership Team with Key Appointments
CareDx Builds for the Future by Investing in TalentSOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:...
Analytica Announces Expansion of PeriCoach® Pelvic Health Solution into China
PeriCoach Pelvic floor exercise system for the treatment of stress urinary incontinence PeriCoach will be distributed through extensive network of...
Augmedix Reports Fourth Quarter and Full Year 2020 Financial Results
SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTCQX: AUGX), a leading provider of remote medical documentation...
ONCOTELIC THERAPEUTICS, INC. ANNOUNCES PRESENTATION AT AYURVEDIC PERSPECTIVES ON COVID-19.
AGOURA HILLS, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC) (f/k/a Mateon Therapeutics,...
Psyence Group and Pure Extracts Sign JV Letter of Intent for the Extraction of Psilocybin from Psychedelic Mushrooms and Development of Psilocybin Formulations
VANCOUVER, British Columbia, March 31, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence”), and Pure Extracts Technologies Corp....
Cancer Genetics and StemoniX Announce Merger Closing
Cancer Genetics, Inc. Renamed to Vyant Bio, Inc. Vyant Bio, Inc. will begin trading on Nasdaq under the symbol VYNT...
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year...
Affimed and NKMax America Announce FDA Clearance of IND Application to Study the Combination of AFM24, an EGFR Targeted Innate Cell Engager, with SNK-01 Natural Killer Cell Therapy in Solid Tumors
Heidelberg, Germany and Santa Ana, Calif., March 31, 2021 - Affimed N.V. (NASDAQ: AFMD), a clinical-stage immuno-oncology company, and NKMax...
Breakthrough on COVID-19 Vaccine Acknowledged by Global WholeHealth Partners, Corp. (OTC:GWHP) as AstraZeneca Aims to File Application With FDA While Dr. Anthony Fauci Says, “This is Very Likely a Very Good Vaccine”
San Clemente, CA, March 31, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp (OTC:GWHP) offers one of the...
Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globulin (IgG) Treatment for Coronavirus Disease (COVID-19)
As Previously Reported, 11 of the 12 Patients Recovered and were Discharged from Hospital; Seven Patients were Discharged at or...
Capital Senior Living Corporation Announces Fourth Quarter and Full Year 2020 Results
DALLAS, March 31, 2021 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU), one of the nation’s leading...
New Accelerator BioTools Innovator Launches to Support World’s Leading Life Science Tools Startups
- Applications Open Today for Companies Developing Biotechnology Products, Diagnostic and Drug Discovery Platforms, and Research and Development Services -...